Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.
FLETCHER
A P
AP
ALKJAERSIG
N
N
SHERRY
S
S
D001778:Blood Coagulation Disorders; D005337:Fibrin; D005340:Fibrinogen; D005342:Fibrinolysis; D006474:Hemorrhagic Disorders / Q000209:etiology*; D006801:Humans; D010949:Plasma; D059748:Proteolysis; D015912:Thrombolytic Therapy
D005337:Fibrin; D005340:Fibrinogen
FIBRIN; FIBRINOGEN; FIBRINOLYSIS; HEMORRHAGIC DIATHESIS/etiology